Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

BJU Int. 2003 Mar;91(5):438-45. doi: 10.1046/j.1464-410x.2003.03066.x.

Authors

A Sciarra¹, G Mariotti, V Gentile, G Voria, A Pastore, S Monti, F Di Silverio

Affiliation

¹ Department of Urology 'U. Bracci', University La Sapienza, Rome, Italy. sciarrajr@hotmail.com

PMID: 12603395
DOI: 10.1046/j.1464-410x.2003.03066.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use
Biomarkers, Tumor / blood
Cell Differentiation
Cell Transformation, Neoplastic
Humans
Male
Neuroendocrine Tumors / drug therapy
Neuroendocrine Tumors / pathology*
Neurosecretory Systems / cytology*
Prostate / cytology*
Prostate / pathology
Prostatic Hyperplasia / pathology
Prostatic Intraepithelial Neoplasia / pathology
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology*

Substances

Antineoplastic Agents, Hormonal
Biomarkers, Tumor